(Q22241715)

PubMed

PubMed publication ID

7 February 2023

RA Rudick

1

R A

Rudick

1 reference

PubMed

PubMed publication ID

12356200

7 February 2023

S Reingold

series ordinal

3

author given names

S

author last names

Reingold

1 reference

PubMed

PubMed publication ID

12356200

Multiple Sclerosis Journal

7 February 2023

publication date

1 October 2002

0 references

published in

1 reference

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

volume

8

0 references

issue

5

0 references

page(s)

359-365

0 references

cites work

1 reference

https://api.crossref.org/works/10.1191/1352458502MS845OA

Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force

20 April 2017

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS845OA

Outcomes assessment in multiple sclerosis clinical trials: a critical analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS845OA

Clinical outcomes assessment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS845OA

Development of a multiple sclerosis functional composite as a clinical trial outcome measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS845OA

Paced auditory serial-addition task: a measure of recovery from concussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS845OA

The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS845OA

Intrarater and interrater reliability of the MS functional composite outcome measure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS845OA

Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS845OA

Employment-seeking experiences of residents in 1996: a window into the neurology marketplace.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS845OA

Concurrent validity of the MS Functional Composite using MRI as a biological disease marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS845OA

Optimizing the association between disability and biological markers in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS845OA

Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS845OA

Comparison of full-field digital mammography with screen-film mammography for cancer detection: results of 4,945 paired examinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS845OA

Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the pooling project. The pooling project research group

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS845OA

7 January 2021

Kurtzke scales revisited: the application of psychometric methods to clinical intuition

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS845OA

7 January 2021

Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS845OA

7 January 2021

The measurement of ambulatory impairment in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS845OA

7 January 2021

MS functional composite: relation to disease phenotype and disability strata

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS845OA

7 January 2021